"Beacon Hospital M'sia is a world class cancer specialist hospital equipped with 100 beds and more than 80 medical specialists. Check out now!"

During the past decade, Beacon Hospital Sdn. Bhd. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beacon Hospital Sdn. Bhd." #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "National Cancer Centre, Singapore" with 2 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beacon Hospital Sdn. Bhd." #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator, "Singapore General Hospital" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Beacon Hospital Sdn. Bhd." are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Lung Cancer" (2 trials), "Advanced or Metastatic Colorectal Cancer" (1 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Beacon Hospital Sdn. Bhd." in a lesser frequency.

Most popular intervention types in "Beacon Hospital Sdn. Bhd." are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (4 trials), "Lazertinib" (4 trials), "Carboplatin" (3 trials), "Pemetrexed" (3 trials) and "Dacomitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beacon Hospital Sdn. Bhd." are 11 trials for "All" genders.

Currently, there are NaN active trials in "Beacon Hospital Sdn. Bhd.". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Beacon Hospital Sdn. Bhd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beacon Hospital Sdn. Bhd., 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".